Interpharm Holdings (Interpharm Holdings) Debt-to-EBITDA : -3.23 (As of Dec. 2007)

Interpharm Holdings Debt-to-EBITDA Chart

Interpharm Holdings Annual Data
	Trend	Jun98	Jun99	Jun00	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07
Debt-to-EBITDA		Get a 7-Day Free Trial					N/A	1.32	14.77	-4.84	-3.24

Interpharm Holdings Quarterly Data
	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07
Debt-to-EBITDA	Get a 7-Day Free Trial															-1.07	-2.48	-1.02	-1.52	-3.23

Competitive Comparison of Interpharm Holdings's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Interpharm Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Interpharm Holdings's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Interpharm Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Interpharm Holdings's Debt-to-EBITDA falls into.

Interpharm Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Interpharm Holdings's Debt-to-EBITDA for the fiscal year that ended in Jun. 2007 is calculated as

Interpharm Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2007 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2007) EBITDA data.

Interpharm Holdings  (GREY:IPAH) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Interpharm Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Interpharm Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Interpharm Holdings (Interpharm Holdings) Business Description